Intraperitoneal Infusion Improves CAR-T Cell Therapy in Solid Tumor Models
In solid tumor models, intraperitoneal infusion improved CAR-T cell antitumor efficacy and persistence compared to standard intravenous delivery.
In solid tumor models, intraperitoneal infusion improved CAR-T cell antitumor efficacy and persistence compared to standard intravenous delivery.
A 2026 review finds that miRNA nanocarriers may help overcome delivery barriers in osteosarcoma, while emphasizing unresolved safety, manufacturing, regulatory ...
An RNA sequencing study of 159 nasopharyngeal carcinoma patients found that an eight-gene ENE-related signature predicted distant metastasis risk and ...
An AI system combining rapid Raman histology with clinical and molecular data can predict where glioblastoma will recur, potentially allowing ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine